Solvonis Therapeutics (SVNS)

Sector:

Pharma and Biotech

0.31p
   
  • Change Today:
    -0.070p
  • 52 Week High: 0.38
  • 52 Week Low: 0.12
  • Currency: UK Pounds
  • Shares Issued: 6,262m
  • Volume: 68,427,520
  • Market Cap: £19.41m

SVNS Overview

Our motto “COMBINE INCOMPATIBLE” defines the essence of our business which is to create polymer modifiers & alloys which combine immiscible and incompatible components of polymers to achieve a versatile range of mechanical characteristics including good impact and chemical resistance, fire retardant properties and cost-effectiveness.

1 Day Chart (14-08-2025)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 6.3  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SVNS Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 0.52 (0.45) (0.65)p n/a n/a n/a n/a 0.0%
31-Dec-21 0.22 (0.95) (1.36)p n/a n/a n/a n/a 0.0%
31-Dec-22 0.54 (2.70) (2.61)p n/a n/a n/a n/a 0.0%
31-Dec-23 0.59 (3.12) (3.00)p n/a n/a n/a n/a 0.0%
31-Dec-24 n/a (1.45) (0.12)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Latest SVNS Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

SVNS Market Data

Currency UK Pounds
Share Price 0.31p
Change Today -0.070p
% Change -18.42 %
52 Week High 0.38
52 Week Low 0.12
Volume 68,427,520
Shares Issued 6,262m
Market Cap £19.41m

SVNS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.21% below the market average45.21% below the market average45.21% below the market average45.21% below the market average45.21% below the market average
2.33% below the sector average2.33% below the sector average2.33% below the sector average2.33% below the sector average2.33% below the sector average
Price Trend
34.74% above the market average34.74% above the market average34.74% above the market average34.74% above the market average34.74% above the market average
37.78% above the sector average37.78% above the sector average37.78% above the sector average37.78% above the sector average37.78% above the sector average
Income Not Available
Growth Not Available

SVNS Dividends

No dividends found

Trades for 14-Aug-2025

Time Volume / Share Price
16:43 13,500,000 @ 0.37p
16:40 17,407 @ 0.31p
16:40 7 @ 0.31p
16:40 17,400 @ 0.31p
16:27 300,574 @ 0.36p

SVNS Key Personnel

CEO Anthony Tennyson
Chair Dennis Purcell
Finance Director Ryan Neats

Top of Page